应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SHTDY 国药控股ADR
休市中 08-07 16:00:00 EDT 延时
资讯
新帖
简况
【特约大V】邓声兴:美通胀难降温,恒指短线或受压回调
金吾财讯 · 07-17
【特约大V】邓声兴:美通胀难降温,恒指短线或受压回调
财报前瞻|国药控股ADR营收结构稳定,机构多持增持观点
财报Agent · 04-16
财报前瞻|国药控股ADR营收结构稳定,机构多持增持观点
暂无数据
公司概况
公司名称:
国药控股ADR
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。
发行价格:
--
{"stockData":{"symbol":"SHTDY","market":"US","secType":"STK","nameCN":"国药控股ADR","latestPrice":10.98,"timestamp":1786132800000,"preClose":10.83,"halted":0,"volume":102593,"delay":15,"changeRate":0.013850415512465407,"floatShares":254921099,"shares":624131238,"eps":1.563169,"marketStatus":"休市中","change":0.15,"latestTime":"08-07 16:00:00 EDT 延时","open":11,"high":11.35,"low":10.98,"amount":1145755.8397,"amplitude":0.034164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.563169,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":10.83,"volumeRatio":1.6575650579271615},"requestUrl":"/m/hq/s/SHTDY/tweets","defaultTab":"tweets","newsList":[{"id":"2652475019","title":"【特约大V】邓声兴:美通胀难降温,恒指短线或受压回调","url":"https://stock-news.laohu8.com/highlight/detail?id=2652475019","media":"金吾财讯","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652475019?lang=zh_cn&edition=full","pubTime":"2026-07-17 09:41","pubTimestamp":1784252478,"startTime":"0","endTime":"0","summary":"金吾财讯 | 恒指周四 收市报25008点,升327点或1.33%。大市全日成交3228元。国指升133点或1.63%,报8318点;科指涨93点或1.98%,报4834点。澜起科技传出涉及操控价格行为,其在南韩的办事处遭搜查,股价泻23%,报278.6元。高盛回吐4.9%,为跌幅最大道指成份股。Nike反弹4.2%,为表现最强道指成份股。美通胀难降温,恒指短线或受压回调。的进口总代上市达成战略合作,进一步印证集团在创新药进口分销领域的不可替代性。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGExMWIwZjY5YWMzZDJiYjI3NzU4NjU1MjcxMDI5NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986112","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0611395673.USD","LU1481107354.HKD","IE0034224299.USD","LU0164865239.USD","LU0572944931.SGD","SGXZ62798434.SGD","LU0211977185.USD","02800","HHImain","07500","BK1224","LU0164880469.USD","02833","BK1163","BK1500","LU0348767384.USD","LU0359201885.HKD","LU0501845795.SGD","LU0593848301.USD","LU0823426308.USD","LU1152091754.HKD","LU1770036033.HKD","LU1807302812.USD","LU1960683339.HKD","SHTDY","03037","LU0231483743.USD","LU1008478684.HKD","BK1197","LU1023057109.AUD","82800","PMRTY","513600","688008","MCHmain","LU1880383366.USD","LU1993786604.SGD","LU0327786744.USD","SGXZ86797644.SGD","LU0348766576.USD","LU0359201612.USD","03115","LU1152091168.USD","LU0149721374.USD","LU0499858602.USD","LU0640798160.USD","LU0345776255.USD","09115","LU0345775950.USD","LU1115378108.SGD","SG9999002950.SGD","LU0531971595.HKD","LU0039217434.USD","01099","03419","07200","HSI","06809","07300","09992","83115","LU2543165471.USD","LU0880133367.SGD","SG9999001069.SGD","LU0072913022.USD","LU0499858438.USD","BK1515","LU0823426480.USD","LU0307460666.USD","LU1880383440.USD","LU0588546209.SGD","LU0871576103.HKD","HSTECH","LU0067412154.USD","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175759732","title":"财报前瞻|国药控股ADR营收结构稳定,机构多持增持观点","url":"https://stock-news.laohu8.com/highlight/detail?id=1175759732","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175759732?lang=zh_cn&edition=full","pubTime":"2026-04-16 10:29","pubTimestamp":1776306541,"startTime":"0","endTime":"0","summary":"国药控股ADR将于2026年04月23日盘后发布最新季度财报,市场关注营收结构与净利率变化对盈利韧性的影响。公司上一季度营收约为5,751.68亿,毛利率为7.24%,归属于母公司股东的净利润为18.48亿,净利率为1.29%,调整后每股收益未披露,同比数据未披露。结合上一季度净利润环比改善与分部业务规模效应,该投行认为公司在维持大体量营收的同时,通过费用管控、回款优化与供应链效率提升,有望稳定净利率表现并平滑利润波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|国药控股ADR营收结构稳定,机构多持增持观点","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHTDY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0262},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0932},{"period":"6month","weight":-0.1824},{"period":"1year","weight":-0.3105},{"period":"ytd","weight":-0.1947}],"description":"国药控股股份有限公司是一家主要从事药品、医疗保健产品及医疗器械批发和零售业务的中国公司。该公司通过四个部门运营业务。医药分销部门为国内外药品及保健品制造商及其他供货商提供分销、物流及其他加值服务。器械分销部门向客户分销医疗器材。医药零售业务部门拥有直接经营或特许经营的零售药局网路。其他业务部门从事药品、化学试剂及实验室用品的制造与销售。","exchange":"PINK LIMITED","name":"国药控股ADR","nameEN":"Sinopharm Group Co. Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股ADR(SHTDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股ADR(SHTDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股ADR,SHTDY,国药控股ADR股票,国药控股ADR股票老虎,国药控股ADR股票老虎国际,国药控股ADR行情,国药控股ADR股票行情,国药控股ADR股价,国药控股ADR股市,国药控股ADR股票价格,国药控股ADR股票交易,国药控股ADR股票购买,国药控股ADR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股ADR(SHTDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股ADR(SHTDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}